Bruce Beutel

Bio:

Prior to building Passkey Therapeutics as the founding CEO, Bruce had over 30 years of leadership experience in drug discovery, business development, venture, and board roles. For 20 years, he served in multiple R&D leadership roles at Abbott Laboratories and Merck, heading research teams in areas ranging from metabolic disease, infectious disease, chemical genomics, high-throughput screening, and pharmacology. Bruce has also worked at 5 different biotech companies prior to Passkey, in roles that included CSO, CBO, COO, and CEO. He has made more than a dozen deals worth an aggregate value of billions of dollars in roles including Executive Director in business development at Merck, CBO at SQZ Biotechnologies, and at Dewpoint Therapeutics, where he was the founding COO and Strategy & Business Officer. Bruce has also been an Entrepreneur-in-Residence at Polaris Innovation Fund and a Venture Partner at Qiming Venture Partners USA, where he supported investment decisions, portfolio companies, and company creation. He received his B.A. in Biology from the University of Chicago and his Ph.D. in Molecular Biology from the University of Wisconsin-Madison.